Page last updated: 2024-11-01

octopamine and Bone Loss, Osteoclastic

octopamine has been researched along with Bone Loss, Osteoclastic in 1 studies

Octopamine: An alpha-adrenergic sympathomimetic amine, biosynthesized from tyramine in the CNS and platelets and also in invertebrate nervous systems. It is used to treat hypotension and as a cardiotonic. The natural D(-) form is more potent than the L(+) form in producing cardiovascular adrenergic responses. It is also a neurotransmitter in some invertebrates.
octopamine : A member of the class of phenylethanolamines that is phenol which is substituted at the para- position by a 2-amino-1-hydroxyethyl group. A biogenic phenylethanolamine which has been found to act as a neurotransmitter, neurohormone or neuromodulator in invertebrates.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sherman, BE1
Chole, RA1

Other Studies

1 other study available for octopamine and Bone Loss, Osteoclastic

ArticleYear
Effects of catecholamines on calvarial bone resorption in vitro.
    The Annals of otology, rhinology, and laryngology, 2001, Volume: 110, Issue:7 Pt 1

    Topics: Animals; Animals, Newborn; Bone Remodeling; Bone Resorption; Calcium; Cells, Cultured; Dose-Response

2001
chemdatabank.com